Korkushko OV, Khavinson VK, Shatilo VB, et al
However, approval at the federal level does not guarantee that your prescribing physician will recommend treatment for someone just entering adulthood, as clinical judgment about long-term medication use remains individualized
The Swedish study found obese MS patients had a 43% higher risk of reaching significant disability compared to those with normal weight
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee
Bone Morphogenetic Protein 2 (BMP2) Induces Growth Suppression and Enhances Chemosensitivity of Human Colon Cancer Cells
In Part 2, we examined how incretin-based treatments for obesity and diabetes could reshape future patterns of morbidity and mortality